Table 2 Odds ratio for clinical recurrence according to Cyr61 expression tertiles
From: Expression of Cyr61 is associated with clinical course in patients with Crohn’s disease
Variables | IHC scores for Cyr61 expression | No. of patients | Prevalence of clinical recurrence | Unadjusted | Adjusted* | ||
|---|---|---|---|---|---|---|---|
OR (95% CI) | P value | OR (95% CI) | P value | ||||
Tertile 1 | < 60 | 27 | 48.1% | 1.0 | 1.0 | ||
Tertile 2 | ≥ 60 and < 80 | 30 | 36.7% | 0.62 (0.25–1.80) | 0.38 | 0.59 (0.18– 1.88) | 0.37 |
Tertile 3 | ≥ 80 | 26 | 19.2% | 0.26 (0.08–0.89) | 0.03 | 0.43 (0.20– 0.92) | 0.03 |
P for trend | 0.03 | 0.02 | |||||